Gain Therapeutics (GANX) executive compensation, 2026 proxy

Gene Mack, Chief Executive Officer, was paid $1.5M in 2025, up 99% from $737,720 the year before.

Filed
April 28, 2026
Annual meeting
June 24, 2026
Pay year
2025
Named executives
2
CEO total pay
$1.5M+99% vs prior year
2025 CEO Salary
$500,000Actual amount earned
2026 CEO Base Salary
$520,000Approved base salary
CEO Option Awards
$802,819Grant date fair value

How Mack was paid

$1.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary34%Option awards55%Non-equity incentive10%All other compensation1%

Named executive officers

ExecutiveTotal
Gene MackChief Executive Officer$1,467,139
Gianluca FuggettaPrincipal Financial Officer$345,074

What changed and why

  • $1.5MChief Executive Officer Gene Mack received a total compensation of $1,467,139 in fiscal year 2025.
  • Gene Mack was appointed as permanent Chief Executive Officer on January 6, 2025.
  • $500KGene Mack received an annual base salary of $500,000 for 2025.
  • Gianluca Fuggetta serves as Senior Vice President Finance and Principal Financial Officer.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.